Walleye Trading LLC Celldex Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $85,918 - $154,470	3,800 Added 475.0%	4,600 $182,000
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $17,815 - $26,222	-700 Reduced 46.67%	800 $22,000
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $45,435 - $57,420	1,500 New	1,500 $50,000
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $69,450 - $113,450	-2,500 Reduced 71.43%	1,000 $44,000
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $79,450 - $131,495	3,500 New	3,500 $98,000
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $445,004 - $633,052	16,100 New	16,100 $548,000
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $456,704 - $720,256	-12,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $370,560 - $716,672	12,800 New	12,800 $691,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.